Sean Rudnick

965 total citations
26 papers, 592 citations indexed

About

Sean Rudnick is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Sean Rudnick has authored 26 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Epidemiology. Recurrent topics in Sean Rudnick's work include Porphyrin Metabolism and Disorders (11 papers), Heme Oxygenase-1 and Carbon Monoxide (11 papers) and Neonatal Health and Biochemistry (6 papers). Sean Rudnick is often cited by papers focused on Porphyrin Metabolism and Disorders (11 papers), Heme Oxygenase-1 and Carbon Monoxide (11 papers) and Neonatal Health and Biochemistry (6 papers). Sean Rudnick collaborates with scholars based in United States. Sean Rudnick's co-authors include Herbert L. Bonkovsky, Lawrence T. Goodnough, Thomas H. Price, Bruce Wang, Natalia Dixon, Mark W. Russo, Ted Xiao, Philip A. Witman, Steven D. Reich and Carol A. Davis and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Cardiology and The American Journal of Gastroenterology.

In The Last Decade

Sean Rudnick

24 papers receiving 569 citations

Peers

Sean Rudnick

HEMAT

PPCH

BIOCH

PRM

Karl Egan Ireland

Cyrus C. Hsia Canada

Yuan‐Bin Yu Taiwan

Mona Beaunoyer Canada

Wenzhong Que China

Hajna Losonczy Hungary

T-H Lin Taiwan

J. R. Jonsson Australia

Linkun Hu China

G Zacchello Italy

Karl Egan Ireland

Sean Rudnick

116 ×0.4

194 ×1.6

HEMAT

62 ×0.6

PPCH

15 ×0.2

BIOCH

85 ×1.0

PRM

Citations per year, relative to Sean Rudnick Sean Rudnick (= 1×) peers Karl Egan

Countries citing papers authored by Sean Rudnick

Since Specialization

Citations

This map shows the geographic impact of Sean Rudnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Rudnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Rudnick more than expected).

Fields of papers citing papers by Sean Rudnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Rudnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Rudnick. The network helps show where Sean Rudnick may publish in the future.

Co-authorship network of co-authors of Sean Rudnick

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Rudnick. A scholar is included among the top collaborators of Sean Rudnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Rudnick. Sean Rudnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Ted, et al.. (2024). Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care. Journal of General Internal Medicine. 40(3). 629–636. 1 indexed citations

Rudnick, Sean, et al.. (2023). Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria. Pharmaceuticals. 17(1). 31–31. 2 indexed citations

Rudnick, Sean, et al.. (2022). Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic. Digestive Diseases and Sciences. 68(5). 1791–1796. 4 indexed citations

Bonkovsky, Herbert L., Sean Rudnick, Michelle Moore, et al.. (2022). S1362 Direct-Acting Antivirals [DAA] Are Effective as Sole Treatment of Porphyria Cutanea Tarda (PCT) With Chronic Hepatitis C [CHC]. The American Journal of Gastroenterology. 117(10S). e978–e978.

Xiao, Ted, et al.. (2022). Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy. Drug Design Development and Therapy. Volume 16. 1827–1845. 24 indexed citations

Rudnick, Sean, et al.. (2021). Givosiran to treat acute porphyria. Drugs of today. 57(1). 47–47. 17 indexed citations

Rudnick, Sean, Jason Conway, & Mark W. Russo. (2021). Current state of endohepatology: Diagnosis and treatment of portal hypertension and its complications with endoscopic ultrasound. World Journal of Hepatology. 13(8). 887–895. 8 indexed citations

Thapar, Manish, Sean Rudnick, & Herbert L. Bonkovsky. (2020). Givosiran, a novel treatment for acute hepatic porphyrias. Expert Review of Precision Medicine and Drug Development. 6(1). 9–18. 12 indexed citations

Rudnick, Sean, et al.. (2019). Benefits of prophylactic heme therapy in severe acute intermittent porphyria. Molecular Genetics and Metabolism Reports. 19. 100450–100450. 29 indexed citations

10.

Bonkovsky, Herbert L., Natalia Dixon, & Sean Rudnick. (2019). Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Molecular Genetics and Metabolism. 128(3). 213–218. 64 indexed citations

11.

Dixon, Natalia, et al.. (2019). Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias. Molecular Genetics and Metabolism. 128(3). 228–235. 17 indexed citations

12.

Rudnick, Sean, Hélio Pedro, John J. Ko, et al.. (2018). The Patient Odyssey to Confirmed Acute Hepatic Porphyria Diagnosis: Clinical Characteristics and Healthcare Utilization of Patients Preceding Diagnosis of Acute Hepatic Porphyria. The American Journal of Gastroenterology. 113(Supplement). S500–S501. 1 indexed citations

13.

Rudnick, Sean & Mark W. Russo. (2017). Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology. 12(3). 265–275. 24 indexed citations

14.

Rudnick, Sean, et al.. (2017). A Randomized Controlled Trial of Procedural Techniques for Large Volume Paracentesis. Annals of Hepatology. 16(2). 279–284. 7 indexed citations

15.

Riggs, Kevin R., et al.. (2012). PS2-25: An Adaptation of Behavioral Pediatric Obesity Treatment for the Real World: Results from the Group Health Family Wellness Program Pilot Trial. Clinical Medicine & Research. 10(3). 185–185. 1 indexed citations

16.

Janardhanan, Rajesh, Zachary Henry, David J. Hur, et al.. (2010). The Snow-Shoveler's ST Elevation Myocardial Infarction. The American Journal of Cardiology. 106(4). 596–600. 23 indexed citations

17.

Henry, David H., Beth Brooks, Jonas Kügler, et al.. (2006). Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.. PubMed. 1(4). 252–60. 36 indexed citations

18.

Goodnough, Lawrence T., et al.. (1992). Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion. 32(5). 441–445. 107 indexed citations

19.

Ernstoff, Marc S., Carol A. Davis, Steven D. Reich, et al.. (1987). A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma.. Journal of Clinical Oncology. 5(11). 1804–1810. 42 indexed citations

20.

Ochs, J, Minnie Abromowitch, Sean Rudnick, & S B Murphy. (1986). Phase I-II study of recombinant alpha-2 interferon against advanced leukemia and lymphoma in children.. Journal of Clinical Oncology. 4(6). 883–887. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact